The Growth of the Medical Cannabis and CBD Markets

Thursday, April 27, 2017 Drug News
Email Print This Page Comment bookmark
Font : A-A+ News Commentary

NEW YORK, April 27, 2017 /PRNewswire/ --

According to a report published

by Grand View Research, the global medical cannabis market is expected to grow from $11.4 billion in 2015 to $55.8 billion by 2025, with a compound annual growth rate of 17.1 percent during
the forecast period. The report claims that the increasing number of countries and U.S. states legalizing medical cannabis is one of the factors that drive the growth in the market. Cannabis for medical use is now legal in 28 U.S. states, including Ohio, Pennsylvania, Florida, Arkansas and North Dakota, which legalized cannabis for medical uses in 2016., Inc. (OTC: CIIX), Aurora Cannabis Inc. (OTC: ACBFF), Canopy Growth Corporation (OTC: TWMJF), Vitality Biopharma Inc. (OTC: VBIO), Kush Bottles, Inc. (OTC: KSHB).

Cannabidiol (CBD) is one of at least 113 active cannabinoids identified in cannabis. Unlike the compound tetrahydrocannabinol (THC), CBD is not psychoactive and has significant medical benefits. According to Hemp Business Journal, the total retail value of hemp products sold in the U.S. in 2016 reached $688 million, while the growth of Hemp CBD contributed significantly to the total sales. Sean Murphy, the Founder and Publisher of Hemp Business Journal, said: "We estimate the hemp industry will grow to $1.8 billion in sales by 2020, led by hemp food, body care, and CBD-based products. The data demonstrates the hemp industry is growing quickly at 22% five year CAGR and being led by food and body care products, with Hemp CBD products showing a 53% AGR.", Inc. (OTCQB: CIIX) on earlier this week announced, "An update on its financial and business achievements for the third quarter of 2017, as well as its outlook for the remainder of the current fiscal year and 2018."

Financial Highlights:

- Filed form 10Q with the U.S. Securities and Exchange Commission (SEC) reflecting significantly higher revenues for the three- and nine-month periods ended February 28, 2017, as compared to the same periods of fiscal 2016. Operating revenues increased 95% and 109%, respectively. - Revenues from the investor relations business continued to grow in the third quarter, accounting for approximately 60% of total revenues.

Business Highlights: - Completed a $5 million private placement with proceeds to be allocated toward the development and branding of hemp-based health production line and retail sales operations; Shanghai & United States office expansions and infrastructure development, among other things. - Officially established and registered CBD Biotechnology Co. Ltd. ('XiBiDi Biotechnology Co. Ltd.'), a wholly-owned foreign entity of CIIX, in the Pudong Free-Trade Area in Shanghai. - Officially launched Chinese language online store operated by CBD Biotechnology Co. Ltd., offering hemp-based health products to the Chinese community. - We have begun a private placement of a new series of our preferred stock offered only to Canadian investors.

According to chief executive officer, Warren Wang, "Development of a line of our hemp-based health products, for the most part, is complete and preparation of related websites, retail channels and marketing campaigns are entering the final stages as well. The Company's hemp-based health products are expected to be available in the North American markets in the coming weeks. CIIX will continue to develop various hemp-based products for distribution and sale all over the world in hopes of helping people to improve their overall health, particularly in the Chinese community. I am grateful for to the investors who have supported our ongoing development plans and look forward to a prosperous year ahead."

Aurora Cannabis Inc. (OTCQX: ACBFF) recently announced that the company has commenced sales of a new product line of ingestible cannabis oils called Aurora Drops. The company's ingestible cannabis oils come in 30 ml glass bottles with a child resistant certified cap and dropper to allow for the easy and accurate dosing of small amounts of the high potency fluids, and are produced using CGMP compliant supercritical CO2 extraction technology, as well as using an MCT carrier oil sourced from coconut oil. Neil Belot, Chief Global Business Development Officer, said: "The launch of our first ingestible oil products represents a major milestone, which promises to add significantly to Aurora's top and bottom line results."

Canopy Growth Corporation (OTC: TWMJF) is a diversified cannabis company, offering diverse brands and curated cannabis strain varieties in dried and oil extract forms. On April 3, 2017, the company announced that it has entered into an agreement to acquire rTrees Producers Limited ("rTrees"). rTrees is a late-stage ACMPR applicant based in Yorkton, Saskatchewan. "Finding the right opportunity to expand our footprint to Western Canada has been an important priority for our team," said Bruce Linton, Chairman & CEO, Canopy Growth. "We are proud to bring the Tweed reputation for high quality cannabis and engaging customer care to Western Canada, partnering with some of the early pioneers in Canada's legal medical cannabis system."

Vitality Biopharma Inc. (OTCQB: VBIO) is dedicated to unlocking the power of cannabinoids for the treatment of serious neurological and inflammatory disorders. Recently, the company announced the release of one of the first clinical reports detailing the ability of cannabinoid therapy to induce remission in a pediatric inflammatory bowel disease patient. The case study describes how the patient's disease could not be controlled by currently-approved pharmaceuticals, and how cannabinoid treatment led to near-immediate clinical improvement that was indicative of disease remission.

Kush Bottles, Inc. (OTCQB: KSHB) provides packaging products and solutions to producers, processors and retailers operating in the regulated medical and recreational cannabis industry. Recently, the company announced a partnership with HIGH TIMES to be the packaging partner for its series of U.S. High Times Cannabis Cup trade shows. Hosted in states that have legalized medical cannabis programs, the Cannabis Cup is the world's leading cannabis trade show, celebrating the emerging legal cannabis industry through competitions, instructional seminars, expositions, celebrity appearances, concerts and product showcases. Kush Bottles will provide high-end, branded glass jars and bags for all Cannabis Cup entrants at every U.S Cannabis Cup trade show taking place during 2017. 

Please SIGN UP NOW at To Receive Alerts on Trending Financial News from all these companies. "The Latest Buzz in Financial News"

Subscribe Now! Watch us report from NYSE

Follow us on Twitter for real time Financial News Updates:

Follow and talk to us on Instagram:

Facebook Like Us to receive live feeds:

About, a leading financial news informational web portal designed to provide the latest trends in Market News, Investing News, Personal Finance, Politics, Entertainment, in-depth broadcasts on Stock News, Market Analysis and Company Interviews. A pioneer in the financially driven digital space, video production and integration of social media, creates 100% unique original content. also provides financial news PR dissemination, branding, marketing and advertising for third parties for corporate news and original content through our unique media platform that includes Newswire Delivery, Digital Advertising, Social Media Relations, Video Production, Broadcasting, and Financial Publications.

Please Note: is not a financial advisory or advisor, investment advisor or broker-dealer and do not undertake any activities that would require such registration. The information provided on (the "Site") is either original financial news or paid advertisements provided [exclusively] by our affiliates (sponsored content),, a financial news media and marketing firm enters into service agreements with the companies which are the subject to the articles posted on the Site or other editorials for advertising such companies. We are not an independent news media provider and therefore do not represent or warrant that the information posted on the Site is accurate, unbiased or complete. receives fees for producing and presenting high quality and sophisticated content on along with other financial news PR media services. does not offer any personal opinions as we purely incorporate public market research along with financial and corporate news. only aggregates or regurgitates financial or corporate news through our unique financial newswire and media platform. We also do not include any personal opinions or commentary. For this release, expects to be compensated three thousand dollars for financial news dissemination and pr services by inc. Our fees may be either a flat cash sum or negotiated number of securities of the companies featured on this site, or a combination thereof. The securities are commonly paid in segments, of which a portion is received upon engagement and the balance is paid on or near the conclusion of the engagement. has signed a two year agreement with inc. for one hundred thousand restricted common shares for continued financial news dissemination and pr services. will always disclose any compensation in securities or cash payments for financial news PR advertising. does not undertake to update any of the information on the Site or continue to post information about any companies the information contained herein is not intended to be used as the basis for investment decisions and should not be considered as investment advice or a recommendation. The information contained herein is not an offer or solicitation to buy, hold or sell any security., members and affiliates are not responsible for any gains or losses that result from the opinions expressed on the Site, company profiles, quotations or in other materials or presentations that it publishes electronically or in print. Investors accept full responsibility for any and all of their investment decisions based on their own independent research and evaluation of their own investment goals, risk tolerance, and financial condition. By accessing this website and any pages thereof, you agree to be bound by the Terms of Use and Privacy Policy, as may be amended from time to time. None of the content issued by constitutes a recommendation for any investor to purchase, hold or sell any particular security, pursue a particular investment strategy or that any security is suitable for any investor. This publication is provided by Each investor is solely responsible for determining whether a particular security or investment strategy is suitable based on their objectives, other securities holdings, financial situation needs, and tax status. You agree to consult with your investment advisor, tax and legal consultant before making any investment decisions. We make no representations as to the completeness, accuracy or timeless of the material provided. All materials are subject to change without notice. Information is obtained from sources believed to be reliable, but its accuracy and completeness are not guaranteed. For our full disclaimer, disclosure and Terms of Use please visit:

For further information: Media Contact: +1-877-601-1879



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z


News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store